共 50 条
- [11] Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
- [17] The killer immunoglobulin-like receptor KIR3DL1 in combination with HLA-Bw4 is protective against multiple sclerosis in African Americans Genes & Immunity, 2016, 17 : 199 - 202
- [20] Under Representation of the Inhibitory KIR3DL1 Molecule and the KIR3DL1+/BW4+ Complex in HIV Exposed Seronegative Individuals JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (09): : 1235 - 1239